Hi Maaze,
I think that you may find that the new Bioscreens product incorporating the SBN IP focuses more on ease of use for both genders (female friendly!). The actual IP in this instance relates not so much to the biochemistry of the process but more to the actaul collection mechanism and usability. Together, this provides the reason for migration to a new product class.
cheers